nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profile
|
Czajka, Hanna |
|
2009 |
27 |
Supplement 3 |
p. 6504-6511 8 p. |
artikel |
2 |
Activation of toll-like receptor signaling pathway for protection against influenza virus infection
|
Wong, J.P. |
|
2009 |
27 |
Supplement 3 |
p. 3481-3483 3 p. |
artikel |
3 |
Altered pathogenicity, immunogenicity, tissue tropism and 3′-7kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos
|
Liu, Shengwang |
|
2009 |
27 |
Supplement 3 |
p. 4630-4640 11 p. |
artikel |
4 |
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
|
Jasani, B. |
|
2009 |
27 |
Supplement 3 |
p. 3401-3404 4 p. |
artikel |
5 |
An E7-based therapeutic vaccine protects mice against HPV16 associated cancer
|
Venuti, Aldo |
|
2009 |
27 |
Supplement 3 |
p. 3395-3397 3 p. |
artikel |
6 |
An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague
|
Yamanaka, Hitoki |
|
2009 |
27 |
Supplement 3 |
p. 80-87 8 p. |
artikel |
7 |
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
|
Peruzzi, Daniela |
|
2009 |
27 |
Supplement 3 |
p. 1293-1300 8 p. |
artikel |
8 |
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine
|
Kitchin, Nicholas |
|
2009 |
27 |
Supplement 3 |
p. 5096-5102 7 p. |
artikel |
9 |
Antibody quantity versus quality after influenza vaccination
|
Feng, JingQi |
|
2009 |
27 |
Supplement 3 |
p. 6358-6362 5 p. |
artikel |
10 |
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan
|
Iriemenam, Nnaemeka C. |
|
2009 |
27 |
Supplement 3 |
p. 62-71 10 p. |
artikel |
11 |
Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus
|
Sirikwin, Siriwan |
|
2009 |
27 |
Supplement 3 |
p. 4350-4354 5 p. |
artikel |
12 |
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials
|
Boge, Thierry |
|
2009 |
27 |
Supplement 3 |
p. 5677-5684 8 p. |
artikel |
13 |
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
|
Sagara, Issaka |
|
2009 |
27 |
Supplement 3 |
p. 3090-3098 9 p. |
artikel |
14 |
A recombinant replication-defective human adenovirus type 3: A vaccine candidate
|
Li, Haitao |
|
2009 |
27 |
Supplement 3 |
p. 116-122 7 p. |
artikel |
15 |
Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs
|
Steenhard, Nina R. |
|
2009 |
27 |
Supplement 3 |
p. 5161-5169 9 p. |
artikel |
16 |
A single-dose combination therapy that both prevents and treats anthrax infection
|
Klinman, Dennis M. |
|
2009 |
27 |
Supplement 3 |
p. 1811-1815 5 p. |
artikel |
17 |
A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
|
Lau, Yuk-Fai |
|
2009 |
27 |
Supplement 3 |
p. 1354-1364 11 p. |
artikel |
18 |
A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics
|
Hu, Shunlin |
|
2009 |
27 |
Supplement 3 |
p. 904-910 7 p. |
artikel |
19 |
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
|
Frasch, Carl E. |
|
2009 |
27 |
Supplement 3 |
p. B112-B116 nvt p. |
artikel |
20 |
Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
|
Zheng, Nuoyan |
|
2009 |
27 |
Supplement 3 |
p. 5001-5007 7 p. |
artikel |
21 |
Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine
|
Nolan, Terry |
|
2009 |
27 |
Supplement 3 |
p. 2410-2413 4 p. |
artikel |
22 |
Brucellosis: The case for live, attenuated vaccines
|
Ficht, Thomas A. |
|
2009 |
27 |
Supplement 3 |
p. D40-D43 nvt p. |
artikel |
23 |
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy)
|
Panatto, D. |
|
2009 |
27 |
Supplement 3 |
p. 3450-3453 4 p. |
artikel |
24 |
Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)
|
Martínez, Ana I. |
|
2009 |
27 |
Supplement 3 |
p. 3496-3498 3 p. |
artikel |
25 |
Characterisation of influenza A viruses with mutations in segment 5 packaging signals
|
Hutchinson, Edward C. |
|
2009 |
27 |
Supplement 3 |
p. 6270-6275 6 p. |
artikel |
26 |
Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3
|
Piesche, Matthias |
|
2009 |
27 |
Supplement 3 |
p. 4718-4723 6 p. |
artikel |
27 |
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
|
Schuller, Elisabeth |
|
2009 |
27 |
Supplement 3 |
p. 2188-2193 6 p. |
artikel |
28 |
Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination
|
Opriessnig, T. |
|
2009 |
27 |
Supplement 3 |
p. 1002-1007 6 p. |
artikel |
29 |
Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge
|
Platt, Ratree |
|
2009 |
27 |
Supplement 3 |
p. 4508-4519 12 p. |
artikel |
30 |
Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector
|
Zhang, Qiwei |
|
2009 |
27 |
Supplement 3 |
p. 1145-1153 9 p. |
artikel |
31 |
Contribution of IRF-3 mediated IFNβ production to DNA vaccine dependent cellular immune responses
|
Shirota, Hidekazu |
|
2009 |
27 |
Supplement 3 |
p. 2144-2149 6 p. |
artikel |
32 |
Control of pertussis—Lessons learnt from a 10-year surveillance programme in Sweden
|
Carlsson, Rose-Marie |
|
2009 |
27 |
Supplement 3 |
p. 5709-5718 10 p. |
artikel |
33 |
Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs
|
Jeuland, Marc |
|
2009 |
27 |
Supplement 3 |
p. 3109-3120 12 p. |
artikel |
34 |
Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada
|
Poirier, Béatrice |
|
2009 |
27 |
Supplement 3 |
p. 7105-7109 5 p. |
artikel |
35 |
Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam
|
Le, Luan T. |
|
2009 |
27 |
Supplement 3 |
p. F130-F138 nvt p. |
artikel |
36 |
Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections
|
Kim, Min-Chul |
|
2009 |
27 |
Supplement 3 |
p. 6688-6694 7 p. |
artikel |
37 |
Development of measles vaccines in Japan
|
Ueda, Shigeharu |
|
2009 |
27 |
Supplement 3 |
p. 3230-3231 2 p. |
artikel |
38 |
Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART
|
Belaunzarán-Zamudio, Pablo F. |
|
2009 |
27 |
Supplement 3 |
p. 7059-7064 6 p. |
artikel |
39 |
Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3–14 years during the annual health examination in private paediatric offices
|
Salleras, L. |
|
2009 |
27 |
Supplement 3 |
p. 3454-3458 5 p. |
artikel |
40 |
Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment
|
Lederman, Edith |
|
2009 |
27 |
Supplement 3 |
p. 375-377 3 p. |
artikel |
41 |
Editorial Board
|
|
|
2009 |
27 |
Supplement 3 |
p. CO2- 1 p. |
artikel |
42 |
Editorial Board
|
|
|
2009 |
27 |
Supplement 3 |
p. CO2- 1 p. |
artikel |
43 |
Editorial Board
|
|
|
2009 |
27 |
Supplement 3 |
p. CO2- 1 p. |
artikel |
44 |
Editorial Board
|
|
|
2009 |
27 |
Supplement 3 |
p. CO2- 1 p. |
artikel |
45 |
Effectiveness of Jeryl Lynn-containing vaccine in Spanish children
|
Castilla, Jesús |
|
2009 |
27 |
Supplement 3 |
p. 2089-2093 5 p. |
artikel |
46 |
Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines
|
Pathangey, Latha |
|
2009 |
27 |
Supplement 3 |
p. 2707-2711 5 p. |
artikel |
47 |
Effects of hydrostatic pressure on the stability and thermostability of poliovirus: A new method for vaccine preservation
|
Ferreira, Evanilce |
|
2009 |
27 |
Supplement 3 |
p. 5332-5337 6 p. |
artikel |
48 |
Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation
|
Cui, Weiguo |
|
2009 |
27 |
Supplement 3 |
p. 2177-2187 11 p. |
artikel |
49 |
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence
|
Bonanni, Paolo |
|
2009 |
27 |
Supplement 3 |
p. A46-A53 nvt p. |
artikel |
50 |
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity
|
Martelli, Paolo |
|
2009 |
27 |
Supplement 3 |
p. 3788-3799 12 p. |
artikel |
51 |
Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media
|
Palmu, Arto A. |
|
2009 |
27 |
Supplement 3 |
p. 1490-1491 2 p. |
artikel |
52 |
Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM)
|
Li, Ruili |
|
2009 |
27 |
Supplement 3 |
p. 2094-2098 5 p. |
artikel |
53 |
Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis
|
Dang, Zhisheng |
|
2009 |
27 |
Supplement 3 |
p. 7339-7345 7 p. |
artikel |
54 |
Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis
|
Kathaperumal, Kumanan |
|
2009 |
27 |
Supplement 3 |
p. 123-135 13 p. |
artikel |
55 |
Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals
|
Rupprecht, Charles E. |
|
2009 |
27 |
Supplement 3 |
p. 7141-7148 8 p. |
artikel |
56 |
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines
|
Yong, Michelle |
|
2009 |
27 |
Supplement 3 |
p. 3313-3318 6 p. |
artikel |
57 |
Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant
|
Cardona, P.J. |
|
2009 |
27 |
Supplement 3 |
p. 2499-2505 7 p. |
artikel |
58 |
Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children
|
Esposito, Susanna |
|
2009 |
27 |
Supplement 3 |
p. 633-635 3 p. |
artikel |
59 |
Field evaluation of a Mycoplasma bovis bacterin in young dairy calves
|
Maunsell, Fiona P. |
|
2009 |
27 |
Supplement 3 |
p. 2781-2788 8 p. |
artikel |
60 |
Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats
|
Laurenzana, Elizabeth M. |
|
2009 |
27 |
Supplement 3 |
p. 7011-7020 10 p. |
artikel |
61 |
Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine
|
Lin, Cheng-Tao |
|
2009 |
27 |
Supplement 3 |
p. 7352-7358 7 p. |
artikel |
62 |
Ginseng stem–leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice
|
Song, Xiaoming |
|
2009 |
27 |
Supplement 3 |
p. 51-55 5 p. |
artikel |
63 |
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
|
Rodgers, Gail L. |
|
2009 |
27 |
Supplement 3 |
p. 3802-3810 9 p. |
artikel |
64 |
Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection
|
Mueller, Ivo |
|
2009 |
27 |
Supplement 3 |
p. 5633-5643 11 p. |
artikel |
65 |
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
|
Hodge, James W. |
|
2009 |
27 |
Supplement 3 |
p. 4475-4482 8 p. |
artikel |
66 |
Health-care provision factors associated with child immunization coverage in a city centre and a rural area in Kabul, Afghanistan
|
Hemat, Shafiqullah |
|
2009 |
27 |
Supplement 3 |
p. 2823-2829 7 p. |
artikel |
67 |
Hepatitis B vaccination failure in celiac disease: Is there a need to reassess current immunization strategies?
|
Leonardi, S. |
|
2009 |
27 |
Supplement 3 |
p. 6030-6033 4 p. |
artikel |
68 |
Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
|
Landrum, Michael L. |
|
2009 |
27 |
Supplement 3 |
p. 4731-4738 8 p. |
artikel |
69 |
Homologous prime-boost strategy in neonate mice using Neisseria lactamica
|
Ito, André Y. |
|
2009 |
27 |
Supplement 3 |
p. 3422-3428 7 p. |
artikel |
70 |
Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV
|
Jones, Bart |
|
2009 |
27 |
Supplement 3 |
p. 1848-1857 10 p. |
artikel |
71 |
Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5
|
Zhou, Mingguang |
|
2009 |
27 |
Supplement 3 |
p. 5271-5277 7 p. |
artikel |
72 |
Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination
|
Zinckgraf, John W. |
|
2009 |
27 |
Supplement 3 |
p. 5393-5401 9 p. |
artikel |
73 |
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content
|
Hendrikx, Lotte H. |
|
2009 |
27 |
Supplement 3 |
p. 6530-6536 7 p. |
artikel |
74 |
Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
|
Weimer, Eric T. |
|
2009 |
27 |
Supplement 3 |
p. 6762-6769 8 p. |
artikel |
75 |
Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial
|
Chiu, Susan S. |
|
2009 |
27 |
Supplement 3 |
p. 4834-4839 6 p. |
artikel |
76 |
Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration
|
Künzi, Valérie |
|
2009 |
27 |
Supplement 3 |
p. 3561-3567 7 p. |
artikel |
77 |
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants
|
Almeida, Volia De Carvalho |
|
2009 |
27 |
Supplement 3 |
p. 3856-3861 6 p. |
artikel |
78 |
Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP12 peptides presented on Johnson grass mosaic virus-like particles
|
Choudhury, Sangeeta |
|
2009 |
27 |
Supplement 3 |
p. 2948-2953 6 p. |
artikel |
79 |
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years
|
Østergaard, Lars |
|
2009 |
27 |
Supplement 3 |
p. 161-168 8 p. |
artikel |
80 |
Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies
|
Le, Thuy T.T. |
|
2009 |
27 |
Supplement 3 |
p. 3053-3062 10 p. |
artikel |
81 |
Importance of subunit vaccine antigen of major Fli C antigenic site of Salmonella Enteritidis II: A challenge trial
|
Toyota-Hanatani, Yukiko |
|
2009 |
27 |
Supplement 3 |
p. 1680-1684 5 p. |
artikel |
82 |
Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006
|
Khumjui, Chowalit |
|
2009 |
27 |
Supplement 3 |
p. F116-F119 nvt p. |
artikel |
83 |
Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate
|
Villarreal, I. |
|
2009 |
27 |
Supplement 3 |
p. 1875-1879 5 p. |
artikel |
84 |
International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007
|
Tondella, M.L. |
|
2009 |
27 |
Supplement 3 |
p. 803-814 12 p. |
artikel |
85 |
Intradermal influenza vaccine for older adults: A randomized controlled multicenter phase III study
|
Arnou, Robert |
|
2009 |
27 |
Supplement 3 |
p. 7304-7312 9 p. |
artikel |
86 |
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice
|
Oma, Keita |
|
2009 |
27 |
Supplement 3 |
p. 3181-3188 8 p. |
artikel |
87 |
Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits
|
Jansen, Angelique G.S.C. |
|
2009 |
27 |
Supplement 3 |
p. 2394-2401 8 p. |
artikel |
88 |
Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
|
Sakou, Irine-Ikbale |
|
2009 |
27 |
Supplement 3 |
p. 4408-4411 4 p. |
artikel |
89 |
In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide
|
Balasse, Emilie |
|
2009 |
27 |
Supplement 3 |
p. 6107-6109 3 p. |
artikel |
90 |
Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults
|
de Voer, Richarda M. |
|
2009 |
27 |
Supplement 3 |
p. 6974-6982 9 p. |
artikel |
91 |
Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model
|
Faisal, Syed M. |
|
2009 |
27 |
Supplement 3 |
p. 6537-6545 9 p. |
artikel |
92 |
Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity
|
Faisal, Syed M. |
|
2009 |
27 |
Supplement 3 |
p. 378-387 10 p. |
artikel |
93 |
Local and regional adverse reactions to BCG-SSI® vaccination: A 12-month cohort follow-up study
|
Dommergues, M.A. |
|
2009 |
27 |
Supplement 3 |
p. 6967-6973 7 p. |
artikel |
94 |
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
|
Rowhani-Rahbar, Ali |
|
2009 |
27 |
Supplement 3 |
p. 5612-5619 8 p. |
artikel |
95 |
Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus
|
Sasaki, Takashi |
|
2009 |
27 |
Supplement 3 |
p. 5174-5177 4 p. |
artikel |
96 |
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan
|
Kao, Jung-Ta |
|
2009 |
27 |
Supplement 3 |
p. 1858-1862 5 p. |
artikel |
97 |
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults
|
Plentz, Annelie |
|
2009 |
27 |
Supplement 3 |
p. 853-856 4 p. |
artikel |
98 |
Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® Children
|
Wittermann, Christoph |
|
2009 |
27 |
Supplement 3 |
p. 1585-1588 4 p. |
artikel |
99 |
Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge
|
Schell, John |
|
2009 |
27 |
Supplement 3 |
p. 979-986 8 p. |
artikel |
100 |
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives
|
Moorthy, Vasee S. |
|
2009 |
27 |
Supplement 3 |
p. 624-628 5 p. |
artikel |
101 |
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase
|
Tsai, Cheguo |
|
2009 |
27 |
Supplement 3 |
p. 6777-6790 14 p. |
artikel |
102 |
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
|
Vesikari, T. |
|
2009 |
27 |
Supplement 3 |
p. 6291-6295 5 p. |
artikel |
103 |
MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
|
Pellegrini, Michele |
|
2009 |
27 |
Supplement 3 |
p. 6959-6965 7 p. |
artikel |
104 |
Modeling vertical transmission of HIV: Imperfect vaccines can be of benefit
|
Sim, Myung Shin K. |
|
2009 |
27 |
Supplement 3 |
p. 7003-7010 8 p. |
artikel |
105 |
Modified intra-cerebral challenge assay for acellular pertussis vaccines: Comparisons among whole cell and acellular vaccines
|
Gaines-Das, R. |
|
2009 |
27 |
Supplement 3 |
p. 6824-6832 9 p. |
artikel |
106 |
Molecular epidemiology of Japanese encephalitis in East Asia
|
Morita, Kouichi |
|
2009 |
27 |
Supplement 3 |
p. 7131-7132 2 p. |
artikel |
107 |
Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity
|
Khan, Sheema |
|
2009 |
27 |
Supplement 3 |
p. 6080-6087 8 p. |
artikel |
108 |
Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein
|
Yuan, Xiaohui |
|
2009 |
27 |
Supplement 3 |
p. 5103-5110 8 p. |
artikel |
109 |
Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera
|
Moreno, Ana |
|
2009 |
27 |
Supplement 3 |
p. 4967-4974 8 p. |
artikel |
110 |
Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load
|
Hoegh-Petersen, Mette |
|
2009 |
27 |
Supplement 3 |
p. 6723-6730 8 p. |
artikel |
111 |
Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity
|
Sun, Hong-Xiang |
|
2009 |
27 |
Supplement 3 |
p. 3984-3991 8 p. |
artikel |
112 |
One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model
|
Fort, M. |
|
2009 |
27 |
Supplement 3 |
p. 4031-4037 7 p. |
artikel |
113 |
Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation
|
Seo, Sang Hwan |
|
2009 |
27 |
Supplement 3 |
p. 5906-5912 7 p. |
artikel |
114 |
Overcoming innate host resistance to vaccination: Employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception
|
Nikolovski, Sonia |
|
2009 |
27 |
Supplement 3 |
p. 5226-5232 7 p. |
artikel |
115 |
Pertussis before and after the introduction of acellular pertussis vaccines in Finland
|
Elomaa, Annika |
|
2009 |
27 |
Supplement 3 |
p. 5443-5449 7 p. |
artikel |
116 |
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine
|
López, Anna |
|
2009 |
27 |
Supplement 3 |
p. 6166-6178 13 p. |
artikel |
117 |
Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis
|
Keiser, Paul B. |
|
2009 |
27 |
Supplement 3 |
p. 6809-6813 5 p. |
artikel |
118 |
Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure
|
O’Brien, Katherine L. |
|
2009 |
27 |
Supplement 3 |
p. 1863-1868 6 p. |
artikel |
119 |
Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics
|
Poolman, Jan |
|
2009 |
27 |
Supplement 3 |
p. 3213-3222 10 p. |
artikel |
120 |
PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants
|
Ichinohe, Takeshi |
|
2009 |
27 |
Supplement 3 |
p. 6276-6279 4 p. |
artikel |
121 |
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
|
Biesova, Zuzana |
|
2009 |
27 |
Supplement 3 |
p. 6234-6238 5 p. |
artikel |
122 |
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus
|
Van Reeth, Kristien |
|
2009 |
27 |
Supplement 3 |
p. 6330-6339 10 p. |
artikel |
123 |
Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence
|
Hung, Hui-Fang |
|
2009 |
27 |
Supplement 3 |
p. 6770-6776 7 p. |
artikel |
124 |
Production of yellow fever virus in microcarrier-based Vero cell cultures
|
Souza, Marta Cristina O. |
|
2009 |
27 |
Supplement 3 |
p. 6420-6423 4 p. |
artikel |
125 |
Protective immunization with homologous and heterologous antigens against Helicobacter suis challenge in a mouse model
|
Flahou, Bram |
|
2009 |
27 |
Supplement 3 |
p. 1416-1421 6 p. |
artikel |
126 |
Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines
|
Franka, Richard |
|
2009 |
27 |
Supplement 3 |
p. 7149-7155 7 p. |
artikel |
127 |
Recombinant glycoprotein based vaccine for Chandipura virus infection
|
Venkateswarlu, C.H. |
|
2009 |
27 |
Supplement 3 |
p. 2845-2850 6 p. |
artikel |
128 |
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
|
Cantarella, Giuseppina |
|
2009 |
27 |
Supplement 3 |
p. 3385-3390 6 p. |
artikel |
129 |
Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
|
Prymula, Roman |
|
2009 |
27 |
Supplement 3 |
p. 4739-4740 2 p. |
artikel |
130 |
Resistance to mycobacterial infection: A pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice
|
Arko-Mensah, John |
|
2009 |
27 |
Supplement 3 |
p. 7418-7427 10 p. |
artikel |
131 |
Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells
|
Hu, Ningjie |
|
2009 |
27 |
Supplement 3 |
p. 2994-3006 13 p. |
artikel |
132 |
Rotavirus surveillance to determine disease burden and epidemiology in Java, Indonesia, August 2001 through April 2004
|
Wilopo, Siswanto Agus |
|
2009 |
27 |
Supplement 3 |
p. F61-F66 nvt p. |
artikel |
133 |
Saccharomyces cerevisiae as a vaccine against coccidioidomycosis
|
Capilla, Javier |
|
2009 |
27 |
Supplement 3 |
p. 3662-3668 7 p. |
artikel |
134 |
Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age
|
Halperin, Scott A. |
|
2009 |
27 |
Supplement 3 |
p. 2540-2547 8 p. |
artikel |
135 |
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
|
Kaltenböck, A. |
|
2009 |
27 |
Supplement 3 |
p. 4483-4489 7 p. |
artikel |
136 |
Scheduling of measles vaccination in low-income countries: Projections of a dynamic model
|
Bauch, C.T. |
|
2009 |
27 |
Supplement 3 |
p. 4090-4098 9 p. |
artikel |
137 |
Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis
|
Ridi, Rashika El |
|
2009 |
27 |
Supplement 3 |
p. 666-673 8 p. |
artikel |
138 |
Sentinel Pap smears in 261 invasive cervical cancer patients in Italy
|
Igidbashian, Sarah |
|
2009 |
27 |
Supplement 3 |
p. A34-A38 nvt p. |
artikel |
139 |
Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
|
Cruciani, Mario |
|
2009 |
27 |
Supplement 3 |
p. 17-22 6 p. |
artikel |
140 |
Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies
|
Pírez, María Catalina |
|
2009 |
27 |
Supplement 3 |
p. 2689-2694 6 p. |
artikel |
141 |
Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario
|
Gasparini, R. |
|
2009 |
27 |
Supplement 3 |
p. 3435-3438 4 p. |
artikel |
142 |
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets
|
Forrest, Heather L. |
|
2009 |
27 |
Supplement 3 |
p. 4187-4195 9 p. |
artikel |
143 |
SIP 3: Epidemic and pandemic use of antivirals Antivirals: "you're still the one..."
|
|
|
2009 |
27 |
Supplement 3 |
p. 6377-6379 3 p. |
artikel |
144 |
The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine
|
Silfverdal, Sven Arne |
|
2009 |
27 |
Supplement 3 |
p. 1601-1608 8 p. |
artikel |
145 |
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe
|
Jit, Mark |
|
2009 |
27 |
Supplement 3 |
p. 6121-6128 8 p. |
artikel |
146 |
The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia
|
Orthopoulos, George V. |
|
2009 |
27 |
Supplement 3 |
p. 350-354 5 p. |
artikel |
147 |
The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine
|
Chattopadhyay, Rana |
|
2009 |
27 |
Supplement 3 |
p. 3675-3680 6 p. |
artikel |
148 |
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
|
Maciag, Paulo Cesar |
|
2009 |
27 |
Supplement 3 |
p. 3975-3983 9 p. |
artikel |
149 |
The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice
|
Salem, Mohamed L. |
|
2009 |
27 |
Supplement 3 |
p. 549-557 9 p. |
artikel |
150 |
TLR expression and NK cell activation after human yellow fever vaccination
|
da Costa Neves, Patrícia Cristina |
|
2009 |
27 |
Supplement 3 |
p. 5543-5549 7 p. |
artikel |
151 |
Toll-like receptor 3 is necessary for dsRNA adjuvant effects
|
Salaun, Bruno |
|
2009 |
27 |
Supplement 3 |
p. 1841-1847 7 p. |
artikel |
152 |
Transcription of immune genes upon challenge with viral hemorrhagic septicemia virus (VHSV) in DNA vaccinated rainbow trout (Oncorhynchus mykiss)
|
Cuesta, A. |
|
2009 |
27 |
Supplement 3 |
p. 280-289 10 p. |
artikel |
153 |
Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
|
Giezeman, K.M. |
|
2009 |
27 |
Supplement 3 |
p. 2414-2417 4 p. |
artikel |
154 |
Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy
|
Durando, Paolo |
|
2009 |
27 |
Supplement 3 |
p. 3459-3462 4 p. |
artikel |
155 |
Use of standardized patients to examine physicians’ communication strategies when addressing vaccine refusal: A pilot study
|
Bryant, Kristina A. |
|
2009 |
27 |
Supplement 3 |
p. 3616-3619 4 p. |
artikel |
156 |
Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany
|
Poethko-Müller, Christina |
|
2009 |
27 |
Supplement 3 |
p. 2563-2569 7 p. |
artikel |
157 |
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey
|
Duchet-Niedziolka, P. |
|
2009 |
27 |
Supplement 3 |
p. 1523-1529 7 p. |
artikel |
158 |
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis
|
Gaston, J. S. Hill |
|
2009 |
27 |
Supplement 3 |
p. 5432-5434 3 p. |
artikel |
159 |
Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen
|
Mealey, Robert H. |
|
2009 |
27 |
Supplement 3 |
p. 2453-2468 16 p. |
artikel |